BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2666911)

  • 1. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
    Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
    Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
    Paranavitana CM
    Mol Cell Probes; 1998 Oct; 12(5):309-15. PubMed ID: 9778456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
    Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
    Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
    Kumar R; Dunn LL
    Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.
    Kahn SM; Jiang W; Culbertson TA; Weinstein IB; Williams GM; Tomita N; Ronai Z
    Oncogene; 1991 Jun; 6(6):1079-83. PubMed ID: 1676837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
    Santiago FS; Todd AV; Hawkins NJ; Ward RL
    Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of PCR-PIRA for screening of a point mutation at codon 12 in K-ras oncogene obtained from paraffin embedded tissue sections.
    Chewawiwat N; Lulitanond V; Nimmanahaeminda K; Thamprasert K; Nicomrat D; Ponglikitmongkol M
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():329-32. PubMed ID: 8629136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras oncogenes in human cancer: a review.
    Bos JL
    Cancer Res; 1989 Sep; 49(17):4682-9. PubMed ID: 2547513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for point mutations in codons 12, 13, and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers.
    Victor T; Du Toit R; Jordaan AM; Bester AJ; van Helden PD
    Cancer Res; 1990 Aug; 50(16):4911-4. PubMed ID: 2199031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
    Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic alterations of human colorectal cancer].
    Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
    Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
    Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncogenes in human gastric carcinoma].
    Tahara E
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.